Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and DepressionRobert A. Hodgson, John C. Hunter, Geoffrey B. Varty et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 149
NCX 2057, a novel NO‐releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in <i>in vitro</i> and <i>in vivo</i> modelsDaniela Ronchetti, Francesco Impagnatiello|British Journal of Pharmacology|2009Cited by 38